ORLEANS CAPITAL MANAGEMENT CORP/LA

Position in BMY — Bristol Myers Squibb Co

CIK 1013234 MANDEVILLE, LA

Position in BMY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$313,222

-$442,112 QoQ

Shares Held

5,436

-63.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#1,844

of 2,506 holders

Holding Since

Jun 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ORLEANS CAPITAL MANAGEMENT CORP/LA holds $9,372,735 across 5 Drug Manufacturers - General names. BMY ranks #5 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	18,649	$4,692,834
2	JNJ	Johnson & Johnson	8,380	$2,128,268
3	GILD	Gilead Sciences, Inc.	14,186	$1,792,259
4	MRK	Merck & Co., Inc.	3,472	$446,152
5	BMY	Bristol Myers Squibb Co This page	5,436	$313,222

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$313,222	5,436	-63.1%	Shares	Sole	2026-08-12
2023-12-31	$755,334	14,721	-52.4%	Shares	Sole	2024-02-14
2023-09-30	$1,795,931	30,943	-4.5%	Shares	Sole	2023-11-15
2023-06-30	$2,072,491	32,408	-1.5%	Shares	Sole	2023-08-11
2023-03-31	$2,280,160	32,898	+0.2%	Shares	Sole	2023-05-12
2022-12-31	$2,363,413	32,848	+3.2%	Shares	Sole	2023-02-14
2022-09-30	$2,263,007	31,833	-0.5%	Shares	Sole	2022-11-15
2022-06-30	$2,462,691	31,983	+3.0%	Shares	Sole	2022-08-15
2022-03-31	$2,267,435	31,048	+50.7%	Shares	Sole	2022-05-13
2021-12-31	$1,284,285	20,598	-29.7%	Shares	Sole	2022-02-15
2021-09-30	$1,733,089	29,290	-0.6%	Shares	Sole	2021-11-18
2021-06-30	$1,968,183	29,455	-1.3%	Shares	Sole	2021-08-13
2021-03-31	$1,884,746	29,855	+25.2%	Shares	Sole	2021-05-17
2020-12-31	$1,479,725	23,855	-28.9%	Shares	Sole	2021-02-19
2020-09-30	$2,022,428	33,545	-0.4%	Shares	Sole	2020-11-13
2020-06-30	$1,981,266	33,695	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.